CHRU of Lille

Lille 59037

0 studies enrolling now · 1 studies all time

What they study most

KRAS Activating Mutation, Non Small Cell Lung Cancer

Studies at this site

• Phase 1/2 Study of Avutometinib (VS-6766) + Sotorasib With or Without Defactinib in KRAS G12C NSCLC Patients — Running, not enrolling